Cargando…

Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer

Chromodomain-helicase-DNA-binding protein 4 (CHD4) is an epigenetic regulator identified as an oncogenic element that may provide a novel therapeutic target for the treatment of breast cancer (BC). CHD4—the core component of the nucleosome remodeling and deacetylase (NuRD) complex—may be mutated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novillo, Apolonia, Fernández-Santander, Ana, Gaibar, Maria, Galán, Miguel, Romero-Lorca, Alicia, El Abdellaoui-Soussi, Fadoua, Gómez-del Arco, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107472/ https://www.ncbi.nlm.nih.gov/pubmed/33981601 http://dx.doi.org/10.3389/fonc.2021.633233

Ejemplares similares

Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients
por: Romero-Lorca, Alicia, et al.
Publicado: (2015)

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer
por: Gaibar, Maria, et al.
Publicado: (2020)

Genetic Variability of the Functional Domains of Chromodomains Helicase DNA-Binding (CHD) Proteins
por: Cardoso, Ana R., et al.
Publicado: (2021)

Differential expression of PMCA2 mRNA isoforms in a cohort of Spanish patients with breast tumor types
por: Romero-Lorca, Alicia, et al.
Publicado: (2018)

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer
por: Gaibar, María, et al.
Publicado: (2021)

Interplay between the Chd4/NuRD Complex and the Transcription Factor Znf219 Controls Cardiac Cell Identity
por: El Abdellaoui-Soussi, Fadoua, et al.
Publicado: (2022)

FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer
por: Gaibar, María, et al.
Publicado: (2022)

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
por: Novillo, Apolonia, et al.
Publicado: (2023)

Advances in Chromodomain Helicase DNA-Binding (CHD) Proteins Regulating Stem Cell Differentiation and Human Diseases
por: Liu, Caojie, et al.
Publicado: (2021)

The role of chromodomain helicase DNA binding protein 1 (CHD1) in promoting an invasive prostate cancer phenotype
por: Kareddula, Aparna, et al.
Publicado: (2021)

The chromodomain helicase CHD4 regulates ERBB2 signaling pathway and autophagy in ERBB2(+) breast cancer cells
por: D'Alesio, Carolina, et al.
Publicado: (2019)

Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
por: Novillo, Apolonia, et al.
Publicado: (2020)

miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Romero-Lorca, Alicia, et al.
Publicado: (2021)

Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients
por: Fernández-Santander, Ana, et al.
Publicado: (2013)

Frequent Disruption of Chromodomain Helicase DNA-Binding Protein 8 (CHD8) and Functionally Associated Chromatin Regulators in Prostate Cancer
por: Damaschke, Nathan A., et al.
Publicado: (2014)

Gene expression regulation by the Chromodomain helicase DNA-binding protein 9 (CHD9) chromatin remodeler is dispensable for murine development
por: Alendar, Andrej, et al.
Publicado: (2020)

The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes
por: Wilkinson, B, et al.
Publicado: (2015)

Chromodomain Helicase Binding Protein 8 (Chd8) Is a Novel A-Kinase Anchoring Protein Expressed during Rat Cardiac Development
por: Shanks, Maureen O., et al.
Publicado: (2012)

Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer
por: Mu, Qing-Jie, et al.
Publicado: (2015)

Chromodomain-helicase-DNA-binding protein 1-like (CHD1L) silencing inhibits gastric cancer cell proliferation, invasion, and migration
por: Li, Dinuo, et al.
Publicado: (2020)

Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease
por: Alendar, Andrej, et al.
Publicado: (2021)

Pharmacogenetics of ugt genes in North African populations
por: Gaibar, M., et al.
Publicado: (2018)

Overexpression of chromodomain helicase DNA binding protein 5 (CHD5) inhibits cell proliferation and induces cell cycle arrest and apoptosis in chronic myeloid leukemia
por: Xiong, Shilin, et al.
Publicado: (2021)

The chromodomains of CHD1 are critical for enzymatic activity but less important for chromatin localization
por: Morettini, Stefano, et al.
Publicado: (2011)

Role of Chromodomain Helicase DNA binding protein 2 in DNA damage response signaling and tumorigenesis
por: Nagarajan, Prabakaran, et al.
Publicado: (2009)

Variant analysis of the chromodomain helicase DNA‐binding protein 7 in pediatric disorders of sex development
por: Zhang, Beibei, et al.
Publicado: (2019)

Mice lacking the chromodomain helicase DNA-binding 5 chromatin remodeler display autism-like characteristics
por: Pisansky, M T, et al.
Publicado: (2017)

mRNA expression and epigenetic-based role of chromodomain helicase DNA-binding 5 in hepatocellular carcinoma
por: Heidari, Zahra, et al.
Publicado: (2022)

Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer
por: Wu, Xiao, et al.
Publicado: (2012)

Sporadic Case of CHARGE Syndrome With Chromodomain-Helicase-DNA-Binding Protein 7 (CDH7) Gene Mutation
por: Wael Alnahar, Batool, et al.
Publicado: (2020)

ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1
por: Takahashi, Sayuri, et al.
Publicado: (2023)

Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma
por: SU, FA-REN, et al.
Publicado: (2014)

Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer
por: Xu, Li, et al.
Publicado: (2018)

Downregulation of Aedes aegypti chromodomain helicase DNA binding protein 7/Kismet by Wolbachia and its effect on dengue virus replication
por: Asad, Sultan, et al.
Publicado: (2016)

Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis
por: Liu, Wanwei, et al.
Publicado: (2018)

Chromodomain Helicase DNA-Binding Protein 5 Inhibits Renal Cell Carcinoma Tumorigenesis by Activation of the p53 and RB Pathways
por: Huang, Sheng, et al.
Publicado: (2020)

Chromodomain helicase DNA-binding domain 2 maintains spermatogonial self-renewal by promoting chromatin accessibility and mRNA stability
por: Min, Ziqian, et al.
Publicado: (2022)

Genetic variations in chromodomain helicase DNA-binding protein 5, gene-environment interactions and risk of sporadic Alzheimer’s disease in Chinese population
por: Zhu, Xiao, et al.
Publicado: (2018)

Clinical significance of chromodomain helicase/ATPase DNA binding protein 1-like and human mutL homolog 1 gene expression in cholangiocarcinoma
por: Hua, Jingwen, et al.
Publicado: (2018)

CHD4 ensures stem cell lineage fidelity during skeletal muscle regeneration
por: Sreenivasan, Krishnamoorthy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8hril4e5l83e72p27umschqmmi